-
1
Multi-sequence MRI-based nomogram for prediction of human epidermal growth factor receptor 2 expression in breast cancer
Published 2025-02-01Subjects: Get full text
Article -
2
A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline–Taxane Chemotherapy in Early HER-2 Negative Breast Cancer
Published 2024-12-01Subjects: “…human epidermal growth factor receptor 2 negative…”
Get full text
Article -
3
Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence
Published 2019-03-01Subjects: Get full text
Article -
4
Safety and Efficacy of Everolimus Plus Exemestane in Postmenopausal Women with Treatment-refractory Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Adv...
Published 2023-07-01Subjects: “…hormone receptor-positive human epidermal growth factor receptor 2-negative advanced breast cancer…”
Get full text
Article -
5
Clinical characteristics, metastasis patterns, and treatment outcomes of HER2-low breast cancer
Published 2025-02-01Subjects: “…HER2 (human epidermal growth factor receptor 2) status…”
Get full text
Article -
6
Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer
Published 2019-03-01Subjects: Get full text
Article -
7
Characterisation of IGF-1 (rs7136446) and IL-6 (rs1800795) polymorphisms among breast cancer patients in western Algeria
Published 2024-10-01Subjects: Get full text
Article -
8
High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: significant associations with clinical practice implications
Published 2025-01-01Subjects: “…hormone receptors human epidermal growth factor receptor 2 (HER2)…”
Get full text
Article